BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10359105)

  • 1. The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat.
    Del Sorbo L; DeMartino A; Biancone L; Bussolati B; Conaldi PG; Toniolo A; Camussi G
    Eur J Immunol; 1999 May; 29(5):1513-21. PubMed ID: 10359105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
    Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G
    Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation.
    Mayer K; Merfels M; Muhly-Reinholz M; Gokorsch S; Rosseau S; Lohmeyer J; Schwarzer N; Krüll M; Suttorp N; Grimminger F; Seeger W
    Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H811-8. PubMed ID: 12124231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat.
    Del Sorbo L; Arese M; Giraudo E; Tizzani M; Biancone L; Bussolino F; Camussi G
    Eur J Immunol; 2001 Feb; 31(2):376-83. PubMed ID: 11180101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.
    Montrucchio G; Lupia E; Battaglia E; Del Sorbo L; Boccellino M; Biancone L; Emanuelli G; Camussi G
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):80-8. PubMed ID: 10634803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
    Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
    J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist.
    Leitinger N; Watson AD; Faull KF; Fogelman AM; Berliner JA
    Adv Exp Med Biol; 1997; 433():379-82. PubMed ID: 9561175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin-induced migration of monocytes and PECAM-1 phosphorylation are abrogated by PAF receptor antagonists.
    Shen Y; Sultana C; Arditi M; Kim KS; Kalra VK
    Am J Physiol; 1998 Sep; 275(3):E479-86. PubMed ID: 9725815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity.
    Maggirwar SB; Tong N; Ramirez S; Gelbard HA; Dewhurst S
    J Neurochem; 1999 Aug; 73(2):578-86. PubMed ID: 10428053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis.
    Bussolati B; Biancone L; Cassoni P; Russo S; Rola-Pleszczynski M; Montrucchio G; Camussi G
    Am J Pathol; 2000 Nov; 157(5):1713-25. PubMed ID: 11073830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.
    Bussolino F; Arese M; Montrucchio G; Barra L; Primo L; Benelli R; Sanavio F; Aglietta M; Ghigo D; Rola-Pleszczynski MR
    J Clin Invest; 1995 Aug; 96(2):940-52. PubMed ID: 7543496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.
    Subbanagounder G; Leitinger N; Shih PT; Faull KF; Berliner JA
    Circ Res; 1999 Aug; 85(4):311-8. PubMed ID: 10455059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism.
    Frostegård J; Huang YH; Rönnelid J; Schäfer-Elinder L
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):963-8. PubMed ID: 9157962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment.
    Arese M; Ferrandi C; Primo L; Camussi G; Bussolino F
    J Immunol; 2001 Jan; 166(2):1380-8. PubMed ID: 11145723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis.
    Bussolati B; Mariano F; Cignetti A; Guarini A; Cambi V; Foà R; Piccoli G; Camussi G
    J Immunol; 1998 Aug; 161(3):1493-500. PubMed ID: 9686616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro.
    Borman RA; Jewell R; Hillier K
    Br J Pharmacol; 1998 Jan; 123(2):231-6. PubMed ID: 9489610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid.
    Sneddon AA; McLeod E; Wahle KW; Arthur JR
    Biochim Biophys Acta; 2006 Jul; 1761(7):793-801. PubMed ID: 16829183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures.
    Rougier F; Dupuis F; Cornu E; Dulery C; Praloran V; Denizot Y
    J Lipid Mediat Cell Signal; 1997 Jul; 16(3):147-53. PubMed ID: 9246604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.